Cipla moves into stem cells with Stempeutics deal

Cipla has made an indirect foray into the stem cell therapy segment through an alliance with Stempeutics Research, a leading Indian stem cell company.

Cipla has made an indirect foray into the stem cell therapy segment through an alliance with Stempeutics Research, a leading Indian stem cell company.

Under the initial phase of the alliance, Cipla is providing up to Rs500 million ($11.3 million) to support Stempeutics' R&D...

More from Alimentary/Metabolic

More from Therapeutic Category